Pink SheetThe European Medicines Agency has temporarily suspended the use of Valneva’s chikungunya vaccine, Ixchiq, in individuals over 65 years old following reports of serious adverse events in elderly people
Pink SheetThe Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices sprinted through a condensed two-day schedule at its 15-16 April meeting, which originally had been planne
Pink SheetThe terms of the faceoff between the two US Food and Drug Administration-approved chikungunya vaccines shifted more favorably towards Bavarian Nordic ’s Vimkunya after the 16 April meeting of the US
Pink SheetThe newly rescheduled meeting of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will be shorter than the delayed February meeting, likely refle